Citation Impact
Citing Papers
Breast cancer
2019 Standout
The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
2020 Standout
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement
2016
ROS in cancer therapy: the bright side of the moon
2020 Standout
Does Axillary Boost Increase Lymphedema Compared With Supraclavicular Radiation Alone After Breast Conservation?
2008
Anthrazykline in der Krebstherapie
1997 Standout
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
2020
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Epirubicin
1997
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
2013 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Investigational cancer drugs targeting cell metabolism in clinical development
2014
Effectiveness of different accelerated partial breast irradiation techniques for the treatment of breast cancer patients: Systematic review using indirect comparisons of randomized clinical trials
2019
Over-irradiation
2016
Breast Cancer Treatment
2019 Standout
Accelerated partial breast irradiation: Current status with a focus on clinical practice
2018
Works of P. Bastiani being referenced
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial
2015
Loco regional failure pattern after lumpectomy and breast irradiation in 4185 patients with T1 and T2 breast cancer. Implications for nodal irradiation
2006
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results
2000